Back to RGNX
UBS Group AG RGNX Position History
REGENXBIO Inc. • Healthcare
Quarters held
14
Latest value
$137K
Q3 2026
Peak value
$2.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $395K |
| Q3 2025 | $2.1M |
| Q4 2025 | $288K |
| Q4 2025 | $2.7M |
| Q4 2025 | $10K |
| Q1 2026 | $152K |
| Q1 2026 | $1.8M |
| Q1 2026 | $164K |
| Q2 2026 | $176K |
| Q2 2026 | $2.5M |
| Q2 2026 | $274K |
| Q3 2026 | $128K |
| Q3 2026 | $1.5M |
| Q3 2026 | $137K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $137K | 18.2K | — | — |
| Q3 2026 | $1.5M | 198.8K | — | — |
| Q3 2026 | $128K | 17.0K | — | — |
| Q2 2026 | $274K | 22.9K | — | — |
| Q2 2026 | $2.5M | 212.4K | — | — |
| Q2 2026 | $176K | 14.7K | — | — |
| Q1 2026 | $164K | 19.6K | — | — |
| Q1 2026 | $1.8M | 219.8K | — | — |
| Q1 2026 | $152K | 18.1K | — | — |
| Q4 2025 | $10K | 685 | — | — |
| Q4 2025 | $2.7M | 186.0K | — | — |
| Q4 2025 | $288K | 20.0K | — | — |
| Q3 2025 | $2.1M | 221.5K | — | — |
| Q3 2025 | $395K | 40.9K | — | — |
Other funds holding RGNX
$106.8M
$92.2M
$65.8M
$63.7M
$62.9M
$52.3M
$47.2M